JPH07503252A - 置換アザスペラン化合物投与によるhiv誘発エイズ遅延方法 - Google Patents
置換アザスペラン化合物投与によるhiv誘発エイズ遅延方法Info
- Publication number
- JPH07503252A JPH07503252A JP5513407A JP51340793A JPH07503252A JP H07503252 A JPH07503252 A JP H07503252A JP 5513407 A JP5513407 A JP 5513407A JP 51340793 A JP51340793 A JP 51340793A JP H07503252 A JPH07503252 A JP H07503252A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- carbon atoms
- formula
- composition
- straight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9201803.5 | 1992-01-28 | ||
GB929201803A GB9201803D0 (en) | 1992-01-28 | 1992-01-28 | Methods |
PCT/US1993/000730 WO1993014760A2 (fr) | 1992-01-28 | 1993-01-27 | Procedes |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH07503252A true JPH07503252A (ja) | 1995-04-06 |
Family
ID=10709398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5513407A Pending JPH07503252A (ja) | 1992-01-28 | 1993-01-27 | 置換アザスペラン化合物投与によるhiv誘発エイズ遅延方法 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0624089A4 (fr) |
JP (1) | JPH07503252A (fr) |
KR (1) | KR950700068A (fr) |
AU (1) | AU666175B2 (fr) |
CA (1) | CA2128535A1 (fr) |
GB (1) | GB9201803D0 (fr) |
WO (1) | WO1993014760A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007537251A (ja) * | 2004-05-12 | 2007-12-20 | ブリストル−マイヤーズ スクイブ カンパニー | Hivインテグラーゼ阻害剤:環状ピリミジノン化合物 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9315340D0 (en) * | 1993-07-23 | 1993-09-08 | Smithkline Beecham Corp | Methods |
GB9315306D0 (en) * | 1993-07-23 | 1993-09-08 | Smithkline Beecham Corp | Methods |
GB9315351D0 (en) * | 1993-07-23 | 1993-09-08 | Smithkline Beecham Corp | Methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US181704A (en) * | 1876-08-29 | Improvement in flour-dressing machines | ||
US4963557A (en) * | 1987-09-28 | 1990-10-16 | Smithkline Beecham Corporation | Immunomodulatory azaspiranes |
JPH06501468A (ja) * | 1990-09-24 | 1994-02-17 | スミスクライン・ビーチャム・コーポレイション | 方法 |
ZA921120B (en) * | 1991-02-19 | 1993-01-27 | Smithkline Beecham Corp | Cytokine inhibitors |
-
1992
- 1992-01-28 GB GB929201803A patent/GB9201803D0/en active Pending
-
1993
- 1993-01-27 KR KR1019940702596A patent/KR950700068A/ko not_active Application Discontinuation
- 1993-01-27 EP EP93904671A patent/EP0624089A4/en not_active Withdrawn
- 1993-01-27 JP JP5513407A patent/JPH07503252A/ja active Pending
- 1993-01-27 AU AU35951/93A patent/AU666175B2/en not_active Ceased
- 1993-01-27 CA CA002128535A patent/CA2128535A1/fr not_active Abandoned
- 1993-01-27 WO PCT/US1993/000730 patent/WO1993014760A2/fr not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007537251A (ja) * | 2004-05-12 | 2007-12-20 | ブリストル−マイヤーズ スクイブ カンパニー | Hivインテグラーゼ阻害剤:環状ピリミジノン化合物 |
Also Published As
Publication number | Publication date |
---|---|
WO1993014760A3 (fr) | 1993-09-02 |
GB9201803D0 (en) | 1992-03-11 |
AU666175B2 (en) | 1996-02-01 |
KR950700068A (ko) | 1995-01-16 |
EP0624089A1 (fr) | 1994-11-17 |
WO1993014760A2 (fr) | 1993-08-05 |
AU3595193A (en) | 1993-09-01 |
CA2128535A1 (fr) | 1993-08-05 |
EP0624089A4 (en) | 1994-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3133345B2 (ja) | Hivに対して活性な連結環状ポリアミン | |
JP2904827B2 (ja) | 不安および不安抑うつ障害の処置に有用な医薬組成物の調製へのトリフルオロメチルフェニルテトラヒドロピリジンの使用 | |
JP2000517323A (ja) | B型肝炎およびレトロウイルス関連疾患の治療のためのジカフェオイルキナ酸の新規使用および新規カフェオイルキナ酸誘導体 | |
AU614515B2 (en) | A pharmaceutical combination for the prophylaxis and therapy of malaria | |
JPS63310819A (ja) | 抗レトロウイルス活性をもつ糖タンパク処理抑制剤 | |
JPH0232093A (ja) | 抗レトロウィルスジフルオロ化ヌクレオシド類 | |
IL96618A (en) | Pharmaceutical preparations containing a history of fluoroquinolones for the treatment of pneumocystosis | |
JPH07503252A (ja) | 置換アザスペラン化合物投与によるhiv誘発エイズ遅延方法 | |
US5519028A (en) | Antiviral preparations | |
JPH0521891B2 (fr) | ||
JP2013517262A (ja) | 抗エイズ剤としての多環式化合物の医薬的使用 | |
EP0713391A1 (fr) | Procede d'inhibition de la production de virus de l'immunodeficience chez l'homme au moyen d'azaspiranes substitues | |
US5482959A (en) | Method for delaying aids in an HIV infected individual by administration of substituted azaspirane compounds | |
WO1995003042A1 (fr) | Procede d'inhibition de la replication des virus de l'immunodeficience humaine a l'aide d'azaspirannes substitues | |
JPH09500646A (ja) | アザスピランによるhivの治療法 | |
WO1992016200A1 (fr) | Utilisation de derives d'acide hydroxamique pour l'inhibition de la replication virale | |
JPH04108731A (ja) | 抗エイズウイルス剤 | |
JPH09500647A (ja) | 置換アザスピランによるヒト免疫不全ウイルス産生の阻害法 | |
CZ367598A3 (cs) | Použití substituovaného azaspiranu | |
AU684384B2 (en) | Method of treating opportunistic infections with azaspiranes | |
WO2011046901A2 (fr) | Antiviral à large spectre et procédés d'utilisation | |
KR19980702833A (ko) | 인간 헤르페스-바이러스-8을 치료하기 위한 펜시클로비르의 용도 | |
JPH07188032A (ja) | インフルエンザ治療薬 | |
JPH04230322A (ja) | 抗マラリア医薬組成物 | |
MXPA98009596A (en) | Use of azaspiran substituted in the treatment of a |